Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
VRDN
VRDN News & Events
-
Add to Watchlist
Trade VRDN Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
VRDN News
Viridian's Lumvoa Therapy for Thyroid Eye Disease Set to Launch
Jun 30 2026
Yahoo Finance
U.S. Stocks Close Higher, Led by Technology Gains
Jun 29 2026
NASDAQ.COM
US Stocks Rise, Led by Technology Sector Gains
Jun 29 2026
NASDAQ.COM
US Stocks Rise, Led by Technology Sector Gains
Jun 29 2026
NASDAQ.COM
Universe Pharmaceuticals Acquires Best Praise International
Jun 29 2026
Newsfilter
FDA Approves Viridian's Lumvoa for Thyroid Eye Disease
Jun 29 2026
Newsfilter
U.S. Stock Futures Rise, Led by Tech Gains Amid Easing Middle East Tensions
Jun 29 2026
Newsfilter
U.S. Stock Futures Rise as Investor Confidence Rebounds
Jun 29 2026
seekingalpha
Show More News
VRDN Events
No data
VRDN Monitor News
HighVista Strategies Cuts Stake in Viridian Therapeutics Amid FDA Decision
May 20 2026
Viridian Therapeutics reaches 20-day high amid market gains
May 05 2026
Viridian Therapeutics Shares Plunge After Phase 3 Trial Results
Apr 06 2026
Viridian Therapeutics Shares Plunge After Mixed Trial Results
Mar 30 2026
VRDN Earnings Analysis
No Data
People Also Watch
